Dar Al-Shifa Pharmaceuticals Company reported unaudited preliminary earnings results for the full year ended December 31, 2014. For the year, net profit after tax reached $1,746,987, compared with a net profit after tax of $2,117,685 in the audited data for 2013, a net decrease of 17.5%.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
3.35 USD | +4.69% | -.--% | -.--% |
1st Jan change | Capi. | |
---|---|---|
-.--% | 30.15M | |
+32.95% | 700B | |
+26.51% | 569B | |
-4.97% | 358B | |
+18.83% | 330B | |
+3.54% | 287B | |
+15.70% | 236B | |
+6.68% | 202B | |
-9.08% | 197B | |
+6.70% | 161B |
- Stock Market
- Equities
- PHARMACARE Stock
- News Dar Al-Shifa Pharmaceuticals Company
- Dar Al-Shifa Pharmaceuticals Company Reports Unaudited Preliminary Earnings Results for the Full Year Ended December 31, 2014